Company intelligence / Profile preview

National Reference Laboratory for Breast Health

Seattle, Washington, United States

Ownership: Private
Development stage: Other

Overview

Formerly a CLIA-certified high-complexity molecular diagnostic laboratory wholly owned by Atossa Genetics. Its key clinical product was the ForeCYTE Breast Health Test for early risk assessment and detection of breast cancer using nipple aspirate fluid. Participated in published clinical studies on the performance of its collection device and tests, but is now dissolved and non-operational.

Therapeutic areas: Oncology
Modalities: Diagnostic testDevice
Industry: Pathology

Partnerships

Fisher HealthCare

Beyond the preview

Go deeper on National Reference Laboratory for Breast Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on National Reference Laboratory for Breast Health.

Explore the full profile